Literature DB >> 6247441

Comparative neurovirulence and latency of HSV1 and HSV2 following footpad inoculation in mice.

R R McKendall.   

Abstract

The effect of virus dose and animal age on the appearance of acute and latent neurologic infection by HSV1 and HSV2 was studied in Balb/c and ICR mice inoculated in the footpad. At low viral doses HSV2 was found to be 1,500 times more neurovirulent than HSV1. At high doses there was no difference in neurovirulence. Age-acquired resistance to disease was shown to be less complete with HSV2 than with HSV1. Neurovirulence was shown to be associated with spread of infection to the spinal ganglia. The data indicate that the factor(s) responsible for the differential neurovirulence of these two viruses is related to events at the level of the footpad and/or sciatic nerve.

Entities:  

Mesh:

Year:  1980        PMID: 6247441     DOI: 10.1002/jmv.1890050104

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Neuromorphological aspects of experimental herpes infection.

Authors:  A A Mikhailenko; B S Glushkov; L N Adel'son
Journal:  Neurosci Behav Physiol       Date:  1991 Jan-Feb

3.  The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad.

Authors:  J P Engel; T C Madigan; G M Peterson
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.

Authors:  K E Schneweis; H Forstbauer; M Olbrich; M Tag
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

Review 6.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

7.  Role of immediate early protein ICP27 in the differential sensitivity of herpes simplex viruses 1 and 2 to leptomycin B.

Authors:  Donglim Park; Joy Lengyel; Stephen A Rice
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

8.  Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.

Authors:  T Bergström; K Alestig; B Svennerholm; P Horal; B Sköldenberg; A Vahlne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

9.  Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing.

Authors:  Shuang Tang; Nini Guo; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Neurovirulence of individual plaque stocks of Herpes simplex virus type 2 strain HG 52.

Authors:  M Y Taha; S M Brown; G B Clements
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.